(TM) Toyota Motor - Overview
Sector: Consumer CyclicalIndustry: Auto Manufacturers | Exchange NYSE (USA) | Currency USD | Market Cap: 274.535m | Total Return 16.4% in 12m
Stock: Cars, Trucks, Vans, SUVs, Batteries
| Risk 5d forecast | |
|---|---|
| Volatility | 28.0% |
| Relative Tail Risk | -4.68% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.51 |
| Alpha | 3.48 |
| Character TTM | |
|---|---|
| Beta | 0.628 |
| Beta Downside | 0.993 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.92% |
| CAGR/Max DD | 0.47 |
EPS (Earnings per Share)
Revenue
Description: TM Toyota Motor March 05, 2026
Toyota Motor Corporation (TM) is a global automotive manufacturer. The company designs, manufactures, and sells a diverse range of vehicles, including passenger cars, minivans, commercial vehicles, and battery electric vehicles. It operates across multiple continents, with significant presence in Japan, North America, and Europe. The automotive industry is characterized by high capital expenditure and extensive supply chains.
TMs business model extends beyond vehicle sales to include financial services. These services encompass retail and wholesale financing, leasing, and insurance. The company also engages in other ventures, such as telecommunications and operates an automotive information web portal. Toyota and Lexus are its primary vehicle brands. Further research into TMs market share and competitive landscape on ValueRay could provide additional insights.
Headlines to watch out for
- Global vehicle sales volume impacts automotive revenue
- Raw material costs influence production profitability
- Currency exchange rates affect international earnings
- EV battery development drives future market share
- Regulatory emissions standards increase compliance expenses
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 3718.29b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.00 > 0.02 and ΔFCF/TA 0.89 > 1.0 |
| NWC/Revenue: 16.73% < 20% (prev 13.52%; Δ 3.21% < -1%) |
| CFO/TA 0.05 > 3% & CFO 4638.74b > Net Income 3718.29b |
| Net Debt (34232.13b) to EBITDA (7344.02b): 4.66 < 3 |
| Current Ratio: 1.26 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.30b) vs 12m ago -0.61% < -2% |
| Gross Margin: 17.62% > 18% (prev 0.20%; Δ 1.74k% > 0.5%) |
| Asset Turnover: 51.44% > 50% (prev 49.38%; Δ 2.07% > 0%) |
| Interest Coverage Ratio: 54.33 > 6 (EBITDA TTM 7344.02b / Interest Expense TTM 92.44b) |
Altman Z'' 2.81
| A: 0.08 (Total Current Assets 41055.28b - Total Current Liabilities 32575.47b) / Total Assets 102414.46b |
| B: 0.37 (Retained Earnings 37798.47b / Total Assets 102414.46b) |
| C: 0.05 (EBIT TTM 5021.96b / Avg Total Assets 98544.44b) |
| D: 0.69 (Book Value of Equity 42966.70b / Total Liabilities 62394.62b) |
| Altman-Z'' Score: 2.81 = A |
Beneish M -0.31
| DSRI: 4.11 (Receivables 17104.02b/3839.90b, Revenue 50693.69b/46746.15b) |
| GMI: 1.15 (GM 17.62% / 20.31%) |
| AQI: 0.95 (AQ_t 0.43 / AQ_t-1 0.45) |
| SGI: 1.08 (Revenue 50693.69b / 46746.15b) |
| TATA: -0.01 (NI 3718.29b - CFO 4638.74b) / TA 102414.46b) |
| Beneish M-Score: -0.31 (Cap -4..+1) = D |
What is the price of TM shares?
Over the past week, the price has changed by +0.83%, over one month by -14.71%, over three months by -4.49% and over the past year by +16.36%.
Is TM a buy, sell or hold?
- StrongBuy: 2
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the TM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 257.2 | 24.4% |
| Analysts Target Price | 257.2 | 24.4% |
TM Fundamental Data Overview March 25, 2026
P/E Trailing = 11.8072
P/E Forward = 11.0988
P/S = 0.0054
P/B = 1.0957
P/EG = 1.5387
Revenue TTM = 50693.69b JPY
EBIT TTM = 5021.96b JPY
EBITDA TTM = 7344.02b JPY
Long Term Debt = 25064.92b JPY (from longTermDebt, last quarter)
Short Term Debt = 17074.41b JPY (from shortTermDebt, last quarter)
Debt = 42156.44b JPY (from shortLongTermDebtTotal, last quarter)
Net Debt = 34232.13b JPY (from netDebt column, last quarter)
Enterprise Value = 78086.90b JPY (43849.37b + Debt 42156.44b - CCE 7918.91b)
Interest Coverage Ratio = 54.33 (Ebit TTM 5021.96b / Interest Expense TTM 92.44b)
EV/FCF = 469.9x (Enterprise Value 78086.90b / FCF TTM 166.16b)
FCF Yield = 0.21% (FCF TTM 166.16b / Enterprise Value 78086.90b)
FCF Margin = 0.33% (FCF TTM 166.16b / Revenue TTM 50693.69b)
Net Margin = 7.33% (Net Income TTM 3718.29b / Revenue TTM 50693.69b)
Gross Margin = 17.62% ((Revenue TTM 50693.69b - Cost of Revenue TTM 41762.28b) / Revenue TTM)
Gross Margin QoQ = 17.77% (prev 15.91%)
Tobins Q-Ratio = 0.76 (Enterprise Value 78086.90b / Total Assets 102414.46b)
Interest Expense / Debt = 0.09% (Interest Expense 38.53b / Debt 42156.44b)
Taxrate = 24.04% (418.62b / 1741.23b)
NOPAT = 3814.60b (EBIT 5021.96b * (1 - 24.04%))
Current Ratio = 1.26 (Total Current Assets 41055.28b / Total Current Liabilities 32575.47b)
Debt / Equity = 1.08 (Debt 42156.44b / totalStockholderEquity, last quarter 39001.30b)
Debt / EBITDA = 4.66 (Net Debt 34232.13b / EBITDA 7344.02b)
Debt / FCF = 206.0 (Net Debt 34232.13b / FCF TTM 166.16b)
Total Stockholder Equity = 37114.61b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.77% (Net Income 3718.29b / Total Assets 102414.46b)
RoE = 10.02% (Net Income TTM 3718.29b / Total Stockholder Equity 37114.61b)
RoCE = 8.08% (EBIT 5021.96b / Capital Employed (Equity 37114.61b + L.T.Debt 25064.92b))
RoIC = 4.97% (NOPAT 3814.60b / Invested Capital 76781.78b)
WACC = 4.21% (E(43849.37b)/V(86005.81b) * Re(8.19%) + D(42156.44b)/V(86005.81b) * Rd(0.09%) * (1-Tc(0.24)))
Discount Rate = 8.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.72%
[DCF] Terminal Value 87.18% ; FCFF base≈166.16b ; Y1≈181.70b ; Y5≈230.49b
[DCF] Fair Price = N/A (negative equity: EV 6783.04b - Net Debt 34232.13b = -27449.09b; debt exceeds intrinsic value)
EPS Correlation: 51.19 | EPS CAGR: 21.31% | SUE: 0.18 | # QB: 0
Revenue Correlation: 93.62 | Revenue CAGR: 15.00% | SUE: 0.05 | # QB: 0
EPS next Quarter (2026-06-30): EPS=4.76 | Chg7d=+0.047 | Chg30d=+0.047 | Revisions Net=+1 | Analysts=1
EPS next Year (2027-03-31): EPS=22.16 | Chg7d=+1.555 | Chg30d=+1.775 | Revisions Net=+2 | Growth EPS=+20.7% | Growth Revenue=+4.5%